Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
clinical trials
san francisco blog main
drugs
san francisco
san francisco top stories
alphabet
biological drugs
boston
boston blog main
boston top stories
drug delivery
fda
gene editing
google
gv
insulin
medical device
mir imran
national top stories
novartis
octreotide
rani therapeutics
roboticsai
shire
startups
takeda pharmaceutical
allergan
american association for cancer research astrazeneca
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
clinical study
crispr
cynthia collins
What
humans
5
×
available
biological
biologics
can’t
cells
clears
convenience
digestive
drugs
editing
enzymes
experimental
gene
hurdle
medicine
pill
proteins
rani’s
robotic
survive
swallowing
that’s
therapeutics
therapies
trial
ago
allergan
benefit
biotechs
blessing
bosley
ceo
check
clinical
considering
crispr
cusp
data
depart
Language
unset
Current search:
humans
×
biotech
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
